Multiplex Assays Market by Product (Consumables, Instruments), Type (Nucleic Acid, Protein, Cell), Technology (Flow Cytometry, Luminescence), Application (R&D, Diagnosis), End User (Pharma & Biotech, Reference Laboratory, Hospital) - Global Forecast to 2023
By: marketsandmarkets.com
Publishing Date: June 2018
Report Code: BT 4473
The global multiplex assays market is projected to reach USD 3.35 Billion in 2023 from USD 2.17 Billion in 2017, at CAGR of 7.5%. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023. In the current market scenario, there is a growing demand for multiplex assays. The major factors driving the growth of the market include the adoption of companion diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays.
Objectives of the Study
- To define, describe, and forecast the multiplex assays market on the basis of product & service, type, technologies, applications, end users, and regions
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
- To profile the key players in the market and comprehensively analyze their market positions and core competencies
- To track and analyze competitive developments such as partnerships, agreements, and joint ventures; mergers and acquisitions; product development; and research and development activities in the multiplex assays market
Research Methodology
Top-down and bottom-up approaches were used to validate the size of the global multiplex assays market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market presence was studied through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, white papers, medical journals, certified publications, articles from recognized authors, directories, and databases such as Statista, World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), Centers for Disease Control and Prevention (CDC), International Cytokine and Interferon Society (ICIS), Diagnostic Marketing Association, American Clinical Laboratory Association (ACLA), National Health Service (NHS), whereas primary research included extensive interviews with key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the segments were determined using secondary sources and verified through primary sources. This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.
To know about the assumptions considered for the study, download the pdf brochure
The key players in the global multiplex assays market are Luminex (US), Bio-Rad Laboratories (US), Becton Dickinson (US), Illumina (US), and Thermo Fisher Scientific (US).
Target Audience:
- Manufacturers of multiplex assay equipment
- Hospitals
- Reference laboratories
- Pharmaceutical companies
- Academic research institutes
- Biotechnology companies
- Suppliers & distributors of multiplex assay equipment
- Government associations
Scope of the Report
The research report categorizes the global multiplex assays market into the following segments and subsegments:
- Multiplex Assays Market, by Product & Service
- Consumables
- Instruments
- Software & Services
- Multiplex Assays Market, by Type
- Protein Assays
- Planar
- Bead-based
- Other
- Nucleic Acid Assays
- Planar
- Bead-based
- Other
- Cell-based Assays
- Protein Assays
- Multiplex Assays Market, by Technology
- Flow Cytometry
- Fluorescence Detection
- Luminescence
- Multiplex RT PCR
- Other Technologies (Liquid chromatographymass spectrometry (LC-MS), dPCR, and colorimetric detection)
- Multiplex Assays Market, by Application
- Research & Development
- Drug Discovery & Development
- Biomarker Discovery and Validation
- Clinical Diagnostics
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Autoimmune Disease
- Nervous System Disorders
- Metabolism & Endocrinology Disorders
- Other Diseases
- Research & Development
- Multiplex Assays Market, by End User
- Pharmaceutical & Biotechnology Companies
- Hospitals & Academic Research Institutes
- Reference Laboratories
- Other End Users (blood banks, CROs, and forensic labs)
- Multiplex assays Market, by Region
- North America
- US
- Canada
- Europe
- Asia Pacific
- Rest of the World (RoW)
- North America
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the report:
Geographical Analysis
Further breakdown of the Europe multiplex assays market into Germany, France, the UK, Italy, and Spain
Further breakdown of the APAC multiplex assays market into India, China, Japan, and Australia
Company Information
Detailed analysis and profiling of additional market players (up to 5)
Table of Contents
1 Introduction (Page No. - 13)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 16)
2.1 Primary Data
2.1.1 Key Data From Primary Sources
2.1.2 Key Industry Insights
2.2 Secondary Data
2.2.1 Key Data From Secondary Sources
2.3 Market Size Estimation
2.4 Market Breakdown and Data Triangulation
2.4.1 Assumptions for the Study
3 Executive Summary (Page No. - 24)
4 Premium Insights (Page No. - 28)
4.1 Multiplex Assays Market Overview
4.2 North America: Market, By Application and Country (2018)
4.3 Market, By Product & Service (2018 vs 2023)
4.4 Geographical Snapshot of the Market
5 Market Overview (Page No. - 31)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Use of Multiplex Assays in Companion Diagnostics
5.2.1.2 Advantages Over Singleplex and Traditional Assays
5.2.2 Restraints
5.2.2.1 High Equipment Costs
5.2.2.2 Stringent Regulations and Standards
5.2.3 Opportunities
5.2.3.1 Increasing Validation of Biomarkers in Molecular and Protein Diagnostics
5.2.3.2 Need for High-Throughput and Automated Systems
6 Multiplex Assays Market, By Product and Service (Page No. - 34)
6.1 Introduction
6.2 Consumables
6.3 Instruments
6.4 Software and Services
7 Multiplex Assays Market, By Type (Page No. - 39)
7.1 Introduction
7.2 Protein Multiplex Assays
7.2.1 Planar Protein Assays
7.2.2 Bead-Based Protein Assays
7.2.3 Other Protein Assays
7.3 Nucleic Acid Multiplex Assays
7.3.1 Planar Nucleic Acid Assays
7.3.2 Bead-Based Nucleic Acid Assays
7.3.3 Other Nucleic Acid Assays
7.4 Cell-Based Multiplex Assays
8 Multiplex Assays Market, By Technology (Page No. - 51)
8.1 Introduction
8.2 Flow Cytometry
8.3 Fluorescence Detection
8.4 Luminescence
8.5 Multiplex Real-Time PCR
8.6 Other Technologies
9 Multiplex Assays Market, By Application (Page No. - 59)
9.1 Introduction
9.2 Research & Development
9.2.1 Drug Discovery & Development
9.2.2 Biomarker Discovery & Validation
9.3 Clinical Diagnostics
9.3.1 Infectious Diseases
9.3.2 Cancer
9.3.3 Cardiovascular Diseases
9.3.4 Autoimmune Diseases
9.3.5 Nervous System Disorders
9.3.6 Metabolism & Endocrinology Disorders
9.3.7 Other Diseases
10 Multiplex Assays Market, By End User (Page No. - 73)
10.1 Introduction
10.2 Pharmaceutical & Biotechnology Companies
10.3 Hospitals & Research Institutes
10.4 Reference Laboratories
10.5 Other End Users
11 Multiplex Assays Market, By Region (Page No. - 79)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.3 Europe
11.4 Asia Pacific
11.5 Rest of the World
12 Competitive Landscape (Page No. - 98)
12.1 Overview
12.2 Market Ranking Analysis, 2017
12.3 Competitive Situation and Trends
12.3.1 Product Launches and Approvals
12.3.2 Collaborations, Agreements, and Partnerships
12.3.3 Acquisitions
13 Company Profiles (Page No. - 102)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 Luminex
13.2 Thermo Fisher Scientific
13.3 Illumina
13.4 Bio-Rad Laboratories
13.5 Qiagen
13.6 Abcam
13.7 Becton Dickinson and Company
13.8 Merck
13.9 Agilent Technologies
13.10 Meso Scale Diagnostics
13.11 Randox Laboratories
13.12 Quanterix
13.13 Bio-Techne
13.14 Olink
13.15 Seegene
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.
14 Appendix (Page No. - 133)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Knowledge Store: Marketsandmarkets Subscription Portal
14.4 Introducing RT: Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports
14.7 Author Details
List of Tables (109 Tables)
Table 1 Market, By Product and Service, 20162023 (USD Million)
Table 2 Multiplex Assay Consumables Market, By Region, 20162023 (USD Million)
Table 3 North America: Multiplex Assay Consumables Market, By Country, 20162023 (USD Million)
Table 4 Multiplex Assay Instruments Market, By Region, 20162023 (USD Million)
Table 5 North America: Multiplex Assay Instruments Market, By Country, 20162023 (USD Million)
Table 6 Multiplex Assay Software and Services Market, By Region, 20162023 (USD Million)
Table 7 North America: Multiplex Assay Software and Services Market, By Country, 20162023 (USD Million)
Table 8 Market, By Type, 20162023 (USD Million)
Table 9 Protein Market, By Type, 20162023 (USD Million)
Table 10 Protein Market, By Region, 20162023 (USD Million)
Table 11 North America: Protein Multiplex Assays Market, By Country, 20162023 (USD Million)
Table 12 Planar Protein Assays Market, By Region, 20162023 (USD Million)
Table 13 North America: Planar Protein Assays Market, By Country, 20162023 (USD Million)
Table 14 Bead-Based Protein Assays Market, By Region, 20162023 (USD Million)
Table 15 North America: Bead-Based Protein Assays Market, By Country, 20162023 (USD Million)
Table 16 Other Protein Assays Market, By Region, 20162023 (USD Million)
Table 17 North America: Other Protein Assays Market, By Country, 20162023 (USD Million)
Table 18 Nucleic Acid Multiplex Assays Market, By Type, 20162023 (USD Million)
Table 19 Nucleic Acid Market, By Region, 20162023 (USD Million)
Table 20 North America: Nucleic Acid Market, By Country, 20162023 (USD Million)
Table 21 Planar Nucleic Acid Assays Market, By Region, 20162023 (USD Million)
Table 22 North America: Planar Nucleic Acid Assays Market, By Country, 20162023 (USD Million)
Table 23 Bead-Based Nucleic Acid Assays Market, By Region, 20162023 (USD Million)
Table 24 North America: Bead-Based Nucleic Acid Assays Market, By Country, 20162023 (USD Million)
Table 25 Other Nucleic Acid Assays Market, By Region, 20162023 (USD Million)
Table 26 North America: Other Nucleic Acid Assays Market, By Country, 20162023 (USD Million)
Table 27 Cell-Based Market, By Region, 20162023 (USD Million)
Table 28 North America: Cell-Based Multiplex Assays Market, By Country, 20162023 (USD Million)
Table 29 Multiplex Assys Market, By Technology, 20162023 (USD Million)
Table 30 Market for Flow Cytometry, By Region, 20162023 (USD Million)
Table 31 North America: Market for Flow Cytometry, By Country, 20162023 (USD Million)
Table 32 Market for Fluorescence Detection, By Region, 20162023 (USD Million)
Table 33 North America: Market for Fluorescence Detection, By Country, 20162023 (USD Million)
Table 34 Market for Luminescence, By Region, 20162023 (USD Million)
Table 35 North America: Market for Luminescence, By Country, 20162023 (USD Million)
Table 36 Market for Multiplex RT PCR, By Region, 20162023 (USD Million)
Table 37 North America: Market for Multiplex RT PCR, By Country, 20162023 (USD Million)
Table 38 Market for Other Technologies, By Region, 20162023 (USD Million)
Table 39 North America: Market for Other Technologies, By Country, 20162023 (USD Million)
Table 40 Market, By Application, 20162023 (USD Million)
Table 41 Market for Research & Development, By Type, 20162023 (USD Million)
Table 42 Market for Research & Development, By Region, 20162023 (USD Million)
Table 43 North America: Market for Research & Development, By Country, 20162023 (USD Million)
Table 44 Market for Drug Discovery & Development, By Region, 20162023 (USD Million)
Table 45 North America: Market for Drug Discovery & Development, By Country, 20162023 (USD Million)
Table 46 Market for Biomarker Discovery & Validation, By Region, 20162023 (USD Million)
Table 47 North America: Market for Biomarker Discovery & Validation, By Country, 20162023 (USD Million)
Table 48 Market for Clinical Diagnostics, By Type, 20162023 (USD Million)
Table 49 Market for Clinical Diagnostics, By Region, 20162023 (USD Million)
Table 50 North America: Market for Clinical Diagnostics, By Country, 20162023 (USD Million)
Table 51 Market for Infectious Disease Diagnostics, By Region, 20162023 (USD Million)
Table 52 North America: Market for Infectious Disease Diagnostics, By Country, 20162023 (USD Million)
Table 53 Market for Cancer Diagnostics, By Region, 20162023 (USD Million)
Table 54 North America: Market for Cancer Diagnostics, By Country, 20162023 (USD Million)
Table 55 Market for Cardiovascular Disease Diagnostics, By Region, 20162023 (USD Million)
Table 56 North America: Market for Cardiac Disease Diagnostics, By Country, 20162023 (USD Million)
Table 57 Market for Autoimmune Disease Diagnostics, By Region, 20162023 (USD Million)
Table 58 North America: Market for Autoimmune Disease Diagnostics, By Country, 20162023 (USD Million)
Table 59 Market for Nervous System Disorder Diagnostics, By Region, 20162023 (USD Million)
Table 60 North America: Market for Nervous System Disorder Diagnostics, By Country, 20162023 (USD Million)
Table 61 Market for Metabolism & Endocrinology Disorder Diagnostics, By Region, 20162023 (USD Million)
Table 62 North America: Market for Metabolism & Endocrinology Disorder Diagnostics, By Country, 20162023 (USD Million)
Table 63 Market for Other Disease Diagnostics, By Region, 20162023 (USD Million)
Table 64 North America: Market for Other Disease Diagnostics, By Country, 20162023 (USD Million)
Table 65 Market, By End User, 20162023 (USD Million)
Table 66 Market for Pharmaceutical & Biotechnology Companies, By Region, 20162023 (USD Million)
Table 67 North America: Market for Pharmaceutical & Biotechnology Companies, By Country, 20162023 (USD Million)
Table 68 Market for Hospitals & Research Institutes, By Region, 20162023 (USD Million)
Table 69 North America: Market for Hospital & Research Institutes, By Country, 20162023 (USD Million)
Table 70 Market for Reference Laboratories, By Region, 20162023 (USD Million)
Table 71 North America: Market for Reference Laboratories, By Country, 20162023 (USD Million)
Table 72 Market for Other End Users, By Region, 20162023 (USD Million)
Table 73 North America: Multiplex Assays Market for Other End Users, By Country, 20162023 (USD Million)
Table 74 Market, By Region, 20162023 (USD Million)
Table 75 North America: Multiplex Assays Market, By Country, 20162023 (USD Million)
Table 76 North America: Market, By Product & Service, 20162023 (USD Million)
Table 77 North America: Market, By Type, 20162023 (USD Million)
Table 78 North America: Market, By Technology, 20162023 (USD Million)
Table 79 North America: Market, By Application, 20162023 (USD Million)
Table 80 North America: Market, By End User, 20162023 (USD Million)
Table 81 US: Multiplex Assays Market, By Product & Service, 20162023 (USD Million)
Table 82 US: Market, By Type, 20162023 (USD Million)
Table 83 US: Market, By Technology, 20162023 (USD Million)
Table 84 US: Market, By Application, 20162023 (USD Million)
Table 85 US: Market, By End User, 20162023 (USD Million)
Table 86 Canada: Multiplex Assays Market, By Product & Service, 20162023 (USD Million)
Table 87 Canada: Market, By Type, 20162023 (USD Million)
Table 88 Canada: Market, By Technology, 20162023 (USD Million)
Table 89 Canada: Market, By Application, 20162023 (USD Million)
Table 90 Canada: Market, By End User, 20162023 (USD Million)
Table 91 Europe: Multiplex Assays Market, By Product & Service, 20162023 (USD Million)
Table 92 Europe: Market, By Type, 20162023 (USD Million)
Table 93 Europe: Market, By Technology, 20162023 (USD Million)
Table 94 Europe: Market, By Application, 20162023 (USD Million)
Table 95 Europe: Market, By End User, 20162023 (USD Million)
Table 96 Asia Pacific: Multiplex Assays Market, By Product & Service, 20162023 (USD Million)
Table 97 Asia Pacific: Market, By Type, 20162023 (USD Million)
Table 98 Asia Pacific: Market, By Technology, 20162023 (USD Million)
Table 99 Asia Pacific: Market, By Application, 20162023 (USD Million)
Table 100 Asia Pacific: Market, By End User, 20162023 (USD Million)
Table 101 RoW: Multiplex Assays Market, By Product & Service, 20162023 (USD Million)
Table 102 RoW: Market, By Type, 20162023 (USD Million)
Table 103 RoW: Market, By Technology, 20162023 (USD Million)
Table 104 RoW: Market, By Application, 20162023 (USD Million)
Table 105 RoW: Market, By End User, 20162023 (USD Million)
Table 106 Rank of Companies in the Multiplex Assays Market, 2017
Table 107 Product Launches and Approvals, 20152018
Table 108 Collaborations, Partnerships, and Agreements, 20152018
Table 109 Acquisitions, 20152018
List of Figures (32 Figures)
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Data Triangulation
Figure 6 Market, By Product & Service, 2018 vs 2023 (USD Million)
Figure 7 Market, By Type, 2018 vs 2023 (USD Million)
Figure 8 Market, By Technology, 2018 vs 2023 (USD Million)
Figure 9 Market, By Application, 2018 vs 2023 (USD Million)
Figure 10 Market, By End User, 2018 vs 2023 (USD Million)
Figure 11 Geographical Snapshot of the Multiplex Assays Market (20182023)
Figure 12 Increasing Adoption of Multiplex Assays in Companion Diagnostics Drives the Growth of the Market
Figure 13 R&D to Account for the Largest Share of the Multiplex Assays Market in North America in 2018
Figure 14 Consumables Segment Will Continue to Dominate the Multiplex Assays Market in 2023
Figure 15 APAC Will Be the Fastest-Growing Market From 2018 to 2023
Figure 16 Global Multiplex Assays Market: Drivers, Restraints, & Opportunities
Figure 17 Geographic Snapshot: Asia Pacific is the Fastest-Growing Region in the Global Multiplex Assays Market
Figure 18 North America: Multiplex Assays Market Snapshot
Figure 19 Asia Pacific: Multiplex Assays Market Snapshot
Figure 20 Key Developments Registered By Leading Players in the Multiplex Assays Market, 2015-2018
Figure 21 Luminex: Company Snapshot (2017)
Figure 22 Thermo Fisher Scientific: Company Snapshot (2017)
Figure 23 Illumina: Company Snapshot ( 2017)
Figure 24 Bio-Rad Laboratories: Company Snapshot ( 2017)
Figure 25 Qiagen: Company Snapshot ( 2017)
Figure 26 Abcam: Company Snapshot (2017)
Figure 27 Becton Dickinson and Company: Company Snapshot (2017)
Figure 28 Merck: Company Snapshot (2017)
Figure 29 Agilent Technologies: Company Snapshot (2017)
Figure 30 Quanterix: Company Snapshot (2017)
Figure 31 Bio-Techne: Company Snapshot (2017)
Figure 32 Seegene: Company Snapshot ( 2017)
The global multiplex assays market is projected to reach USD 3.35 Billion in 2023 from USD 2.33 Billion in 2018, at CAGR of 7.5%. Multiplex assays enables the simultaneous detection of multiple analytes in a single run/cycle of the assay. The use of multiplex assays in companion diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays are driving the growth of the market.
In this report, the market has been categorized based on product & service, type, technology, application, and end user. Based on product and service, the market is segmented into instruments, consumables, and software & services. In 2018, the consumables segment is expected to account for the largest share of the market; it is also the fastest-growing segment of the market. This can be attributed to the recurring purchase of assays and reagents for increasing research applications.
On the basis of type, the global multiplex assays market is divided into protein assays, nucleic acid assays and cell-based assays. In 2018, the protein-based assays segment is expected to account for the largest share of the global market. This large share is attributed to their advantages such as high specificity and sensitivity, easy configuration, minimal usage of samples, and ability to be automated.
In 2018, North America is expected to account for the largest share of the global multiplex assays market. Asia is expected to register the highest growth rate from 2018 to 2023. This can be attributed to its pharmaceutical market which is growing at the fastest pace in the world, the availability of a large number of qualified researchers, and increasing prevalence of cancer and infectious diseases.
The high cost of multiplex assay equipment & standardization of immunoassay design and quality control are the major factors expected to restrain market growth.
The key players in the global multiplex assays market include Luminex (US), Bio-Rad Laboratories (US), Becton, Dickinson (US), Illumina (US), and Thermo Fisher Scientific (US). These players focus on both organic and inorganic growth strategies such as product launches, partnerships, and agreements to maintain and enhance their market share in the market.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
